PHENOTYPIC-EXPRESSION OF DIABETES SECONDARY TO A T14709C MUTATION OF MITOCHONDRIAL-DNA - COMPARISON WITH MIDD SYNDROME (A3243G MUTATION) - A CASE-REPORT
Bh. Vialettes et al., PHENOTYPIC-EXPRESSION OF DIABETES SECONDARY TO A T14709C MUTATION OF MITOCHONDRIAL-DNA - COMPARISON WITH MIDD SYNDROME (A3243G MUTATION) - A CASE-REPORT, Diabetes care, 20(11), 1997, pp. 1731-1737
OBJECTIVE - To analyze the clinical and biochemical features of a rece
ntly described point mutation of mitochondrial DNA associated with dia
betes. This mutation, characterized by a T14709C transition of a highl
y conserved nucleotide in the region coding for the glutamic acid tRNA
, is heteroplasmic. RESEARCH DESIGN AND METHODS - The phenotypic expre
ssion in the insulin-requiring diabetic proband from the pedigree was
compared to that of diabetic probands from three families with the cla
ssic A3243G mtDNA mutation (maternally inherited diabetes and deafness
[MIDD] syndrome). The same investigations to evaluate pancreatic neur
osensorial and muscle involvement were performed in all four patients.
RESULTS - The natural courses of the diabetes and the hearing defects
were not different between the two mutations. The patient with the 14
709 mutation, however, exhibited a milder alteration of pigmentary epi
thelium of retina and a much more severe muscle involvement, as attest
ed by the clinical expression and the concurrent anomalies of muscle e
nergy production evidenced by P-31 magnetic resonance spectroscopy, co
nfirming the profound impairment of oxidative processes. CONCLUSIONS -
This novel mutation has to be added to the other known mtDNA anomalie
s in order to ascribe some diabetes suspected to arise from mitochondr
ial defects to this nosological framework.